Dinara Utepova

Mrs. Dinara Utepova

RCHD
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
Gulzira ZhussupovaGulzira Zhussupova
Gulzira Zhussupova
DUDinara Utepova
Dinara Utepova
GOGaliya Orazova
Galiya Orazova
SZSaule Zhaldybayeva
Saule Zhaldybayeva
GSGalina Skvirskaya
Galina Skvirskaya
KTKanat Tossekbayev
Kanat Tossekbayev
The purpose of this study is to conduct a comparative analysis of the consumption of antibiotics for systemic use reimbursed by the state in Kazakhstan for 2017–2019 with the Access, Watch, and Reserve classification (AWaRe 2019) of the World Health Organization (WHO). The evaluation of the consumption of antibiotics for systemic use in Kazakhstan for 2017–2019 was carried out using the ATC/DDD methodology in accordance with the WHO AWaRe classification. The study used data on all antibiotics that were centrally purchased by a single purchaser during the study period. To understand how often Access group antibiotics are taken in Kazakhstan, the top-10 most consumed antibiotics were additionally studied. The results of a comparative analysis of the antibiotics for systemic use consumption for 2017–2019 by the Access, Watch, and Reserve groups showed a negative trend of a decrease in the consumption of Access group drugs from 1.17 defined daily dose (DDDs) per 1000 inhabitants per day (DID) (39%) in 2017 to 0.59 DID (30%) in 2019. There is an increase in consumption of Watch group antibiotics from 1.84 DID (61%) in 2017 to 1.37 DID (68%) in 2019, as well as an increase in consumption of Reserve antibiotics from 0.001 DID (0.03%) to 0.4 DID (2.11%). In recent years in Kazakhstan, there has been a decrease in the consumption of Access group antibiotics. In addition, the Watch group antibiotics are widely consumed with a certain upward trend. In 2019, one Reserve antibiotic was included in the top-10 most commonly consumed antibiotics. There is a predominant consumption of parenteral forms of antibiotics for systemic use in the country.

2 February 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
Gulzira ZhussupovaGulzira Zhussupova
Gulzira Zhussupova
GSGalina Skvirskaya
Galina Skvirskaya
VRVladimir Reshetnikov
Vladimir Reshetnikov
VDViktorija M Dragojevic-Simic
Viktorija M Dragojevic-Simic
Nemanja RancicNemanja Rancic
Nemanja Rancic
Mihajlo JakovljevicMihajlo Jakovljevic
Mihajlo Jakovljevic
Antimicrobial agents have a rather special position due to their importance as essential medicines for the treatment of infectious diseases. Evidence-based prescriptions are needed to optimize the use of antimicrobials in humans, as well as to decrease antimicrobial resistance. The aim of this study was to assess the inpatient consumption of antimicrobial drugs for systemic use in the period 2011–2018 in Kazakhstan. This article presents the results of an evaluation of the inpatient use of antibacterial drugs for systemic use (group J01) for the period 2011–2018 using the anatomical therapeutic chemical (ATC) classification)/defined daily dose (DDD) methodology recommended by the World Health Organization. Inpatient antimicrobial utilization is expressed as DDDs/1000 inhabitants/day (DID). The results of the assessment for inpatient antibiotic use (over an eight-year period) showed a decrease in the total consumption of antibiotics for systemic action in Kazakhstan (2011: 12.72 DID; 2018: 2.74 DID). Among oral formulations, levofloxacin was consumed the most, and cefazolin was consumed the most among the parenteral formulations of antimicrobials. The three drugs consumed the most included cefazolin (first-generation cephalosporin), ceftriaxone (third-generation cephalosporin), and cefuroxime (second-generation cephalosporin). The total consumption of antibacterials for systemic action in Kazakhstan decreased during the analyzed period, but there was an irrational use of certain groups of drugs.

26 October 2022 in Electronic Journal of General Medicine
Verified
Journal Article
Open access
PDF file
AAAinur Assan
Ainur Assan
IMIkilas Moldaliyev
Ikilas Moldaliyev
ZKZakira Kerimbayeva
Zakira Kerimbayeva
AGAbduzhappar Gaipov
Abduzhappar Gaipov
DUDinara Utepova
Dinara Utepova
MAMohamad Aljofan
Mohamad Aljofan
Introduction: The rapid development of the pharmaceutical industry has increased the need to assess and monitor the use of medicines. Thus, necessitates the importance of monitoring the appropriate use of medicines including antimicrobials. Objective: Pharmacoeconomic analysis of pharmacotherapy in the nephrology department at a multidisciplinary hospital. Methods: The study is a retrospective analysis of medicine use and expenditure. The study utilized the ABC-VEN analysis of medical use and the WHO-AWaRe-2021 analysis of antibiotic use, to determine the prescription and financial trends of the nephrology department (30 beds) of a multidisciplinary regional hospital (total 844 beds) in Turkestan, Kazakhstan 2018-2021. Results: The analyzed costs of drugs included 116 international nonproprietary names prescribed to patients from the nephrology department during the study period. In total, pharmacotherapy costs increased by 52.6% in 2021 compared to 2018. Five INN drugs were purchased without their inclusion in the Kazakhstan National Medicinal Formulary, such as atropine sulfate, sodium bicarbonate, sodium chloride (crystalline salt), nitroxoline, and nitrofural. The pharmacoeconomics analysis of antibiotics usage for 2018-2021 showed a sharp increase in the%age of costs. Conclusion: The study showed an increase in funding for pharmacotherapy in the department of nephrology, which increases the availability of medicines. However, the trend in prescribing drugs with poor evidence base level, and the increase in the proportion of antibiotic prescription, require immediate intervention including the utilization of clinical pharmacy services for regular assessment of the pharmacoeconomic feasibility of antibiotic therapy. This will improve the quality of medical care and reduce the financial costs.

30 April 2017 in Наука и здравоохранение
Verified
Journal Article
Open access
ЖГЖусупова Г.к.
Жусупова Г.к.
ЖСЖалдыбаева С.с.
Жалдыбаева С.с.
DUDinara Utepova
Dinara Utepova
ЖАЖаменкенова А.а.
Жаменкенова А.а.
Введение. Одним из ключевых принципов рационального использования антибиотиков является качественная и обоснованная оценка их потребления. В данной работе были использованы данные о лекарственных средствах, закупленных Единым дистрибьютором в рамках гарантированного объема бесплатной медицинской помощи за период 2012 – 2016г.г., представленные Комитетом фармации Министерства здравоохранения Республики Казахстан (КФ МЗ РК). Цель. Оценка потребления антибактериальных препаратов системного действия, раздела J01 – антибактериальные препараты системного действия, закупленных в рамках гарантированного объема бесплатной медицинской помощи Единым дистрибьютором, с использованием ATC/DDD методологии, рекомендованной Всемирной организацией здравоохранения. Методы исследования. В статье представлены методологические подходы к проведению расчета потребления антибактериальных препаратов системного действия с использованием ATC/DDD-методологии. Результаты. За исследуемый период с 2012г. по 2016г. потребление парентеральных антибактериальных препаратов системного действия, закупленных в рамках Гарантированного объема бесплатной медицинской помощи уменьшилось почти на 30%. А потребление антибактериальных препаратов орального пути введения оставалось неизменным. Выводы. Результаты анализа показали, в целом, положительную тенденцию снижения потребления антибактериальных препаратов системного действия, закупленных в рамках гарантированного объема бесплатной медицинской помощи. Background. One of the key principles of rational use of antibiotics is high quality and reasonable assessment of their consumption. In this paper we used data on medicines purchased by a Single distributor within the guaranteed volume of free medical care for the period 2012 – 2016 гг, submitted by the Committee of Pharmacy of the Health Ministry of the Republic of Kazakhstan (CP HM RK). Objectives. Evaluation of the consumption of antiinfectives for systemic use, section J01 - antiinfectives for systemic use purchased under the guaranteed volume of free medical care by a single distributor, using the ATC / DDD methodology recommended by the World Health Organization. Methods. The article presents the methodological approaches to the quantification of antibacterials for systemic use within the ATC / DDD-methodology. Results. For the period from 2012 to 2016 the consumption of parenteral antibacterial drugs for systemic use purchased under the guaranteed volume of free medical care decreased by almost 30%. And the oral route of administration antibacterial drugs consumption remained unchanged. Conclusions. The results of the analysis showed a generally positive trend of a decrease in the consumption of antibacterial drugs for systemic use purchased under the guaranteed volume of free medical care. Кіріспе. Антибиотиктерді ұтымды пайдаланудың негізгі принципі олардың тұтынуын сапалы және негізделген бағалауы болып табылады. Осы жұмыста тегін медициналық көмектің кепілді көлемі шеңберінде2012 –2016 жылдары Бірыңғай дистрибьютор арқылысатып алынғандәрілік заттар туралы Қазақстан РеспубликасыДенсаулық сақтауМинистрлігінің Фармация Комитеті (КР ҚРДСМ) ұсынған деректер қолданылды. Мақсаты. Дүниежүзілік денсаулық сақтау ұйымы ұсынғанATC/DDD әдіснамасын қолданып тегін медициналық көмектің кепілдік берілген көлемі шеңберінде Бірыңғай дистрибьютор арқылы сатып алынғанJ01-жүйелі пайдалануға арланған бактерияға қарсы препараттар бөліміне жататын жүйелі пайданалуға арланған бактерияға қарсы препараттардың тұтынуын бағалау. Зерттеу әдістері. МақаладаATC/DDD – әдістемесін қолданып, бактерияға қарсы жүйелік әсерлі препараттарды тұтынуын есептеудің әдістемелік тәсілдері ұсынылған. Нәтижелер. 2012 жылдан 2016 жылға дейінгі зерттеліп отырған кезең бойынша тегін медициналық көмектің кепілді көлемі шеңберінде сатып алынған парентеральды...